Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Biocomposites' STIMULAN Earns CE Mark - Orthopedic Design & Technology
OEM News

Biocomposites’ STIMULAN Earns CE Mark

First calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft tissue.

Biocomposites, an international medical devices company that engineers, manufactures, and markets products for use in infection management in bone and soft tissue, announced its STIMULAN products have gained a new European CE mark approval for mixing with antibiotics: vancomycin, gentamicin and tobramycin, for use in infected bone and soft tissue. 
 
STIMULAN targets high concentrations of antibiotic at the point of infection at levels unachievable systemically—which lowers rates of reinfection, saves costs and improves patient outcomes. The STIMULAN Rapid Cure and STIMULAN Kit products are the first and only calcium matrices that can carry an antibiotic into bone and soft tissue; offering surgeons the flexibility to apply a broad spectrum of ‘off-the-shelf’ antibiotics at concentrations that will support their patient-specific treatment plans.
 
Rhidian Morgan-Jones, Consultant Orthopedic Surgeon, said: “STIMULAN is the only product that allows me to place the appropriate antibiotics in bone and soft tissue when treating very challenging infected cases. It has played a key role in transforming the outcomes of some very difficult cases.”
 
Michael Harris, CEO of Biocomposites, said: “Our goal is to develop and provide products that can significantly improve patient outcomes and decrease hospital readmissions. This is a breakthrough solution for surgeons managing infection, offering them the flexibility to use their chosen antibiotics at patient-specific concentration levels in both bone and soft tissue.”

STIMULAN is already used in over 50,000 cases every year and in thousands of hospitals around the world.  

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters